Answers are grounded in this paper and cite their sources.
Article1 January 1950THE RESPONSE OF ACUTE LEUKEMIA TO THE ADMINISTRATION OF THE FOLIC ACID ANTAGONISTS, AMINOPTERIN AND AMETHOPTERIN: REPORT OF 14 CASESMILTON S. SACKS, M.D., F.A.C.P., GEORGE T. BRADFORD, M.D., EMANUEL B. SCHOENBACH, M.D.MILTON S. SACKS, M.D., F.A.C.P.Search for more papers by this author, GEORGE T. BRADFORD, M.D.Search for more papers by this author, EMANUEL B. SCHOENBACH, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-32-1-80 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptINTRODUCTIONIn June 1948 Farber et al.1presented a preliminary report on the therapy of acute leukemia in children, with the folic acid antagonist, aminopterin, 4-amino pteroylglutamic acid (N-[4-{2,4 diamino-6-pteridyl)-methyl] amino} benzoyl] glutamic acid). Of a group of 16 cases treated, five were reported in some detail. The latter were believed to have experienced temporary remissions. In February, 1949 in a follow-up report,2the senior author stated that approximately 60 cases of acute leukemia in children had been treated with aminopterin and other folic acid antagonists. Fifty per cent of this group of cases were reported to have shown...Bibliography1. FarberDiamondMercerSylvesterWolff SLKRDRFJA: Temporary remissions in acute leukemia in children produced by the folic acid antagonist, Medicine 233: 787, 1948. CrossrefGoogle Scholar2. Farber S: Some observations on the effect of folic acid antagonists on acute leukemia and other forms of incurable cancer, Blood 4: 160-167, 1949. CrossrefMedlineGoogle Scholar3. Dameshek W: The use of folic acid antagonists in the treatment of acute and subacute leukemia, Blood 4: 168-171, 1949. CrossrefMedlineGoogle Scholar4. JacobsonLevinHolt WWCG: Observations on the treatment of acute leukemias with analogues of folic acid, Jr. Lab. and Clin. Med. 23: 1641-1642, 1948. Google Scholar5. PierceAlt MH: Treatment of acute leukemia with aminopterin, Jr. Lab. and Clin. Med. 23: 1642-1643, 1948. Google Scholar6. MeyerFinkSawitskyRowenRitz LMHAMND: Aminopterin (a folic acid antagonist) in the treatment of leukemia, Am. J. Clin. Path. 19: 119-126, 1949. CrossrefMedlineGoogle Scholar7. WolmanEglickDicksteinGithens IJPBJ: Leukemia in childhood, Penn. Med. J. 50: 474-481, 1949. Google Scholar8. Wooley DW: Recent advances in the study of biological competition between structurally related compounds, Physiol. Rev. 27: 308, 1947. CrossrefMedlineGoogle Scholar9. Woods DD: The relation of p-amino benzoic acid to the mechanism of action of sulphanilamide, Brit. J. Exper. Path. 21: 74, 1940. Google Scholar10. AngierBootheHutchingsMowatSembStokstadSubbaRowWallerConsulickFahrenbockHultquistKuhNortheySeegerSuckelsSmith RBJHBLJHJELYCWDBMMEEEHDRJPJM: The structure and synthesis of the liver L. casei factor, Science 150: 667, 1946. CrossrefGoogle Scholar11. FranklinStokstadBeltJukes ALELMT: Biochemical experiments with a synthetic preparation having an action antagonistic to that of pteroyl glutamic acid, J. Biol. Chem. 169: 427, 1947. CrossrefMedlineGoogle Scholar12. SnellPeterson EEWH: Growth factors for bacteria. X. Additional factors required by certain lactic acid bacteria, J. Bact. 39: 273, 1940. CrossrefMedlineGoogle Scholar13. HutchingsBohonosPeterson BLNWH: Growth factors for bacteria. XIII. Purification and properties of an eluate factor required by certain lactic acid bacteria, J. Biol. Chem. 161: 521, 1941. CrossrefGoogle Scholar14. TeplyAxelrodElvehjem LJAECA: Sulfapyridine bacteriostasis of Lactobacillus arabinosus and its counteraction, J. Pharmacol. and Exper. Therap. 77: 207, 1943. Google Scholar15. Miller AK: Folic acid and biotin synthesis of sulfonamide-sensitive and sulfonamide-resistant strains of Escherichia coli , Proc. Soc. Exper. Biol. and Med. 57: 151, 1944. CrossrefGoogle Scholar16. LampenJones JOMJ: Antagonism of sulfonamide inhibition of certain lactobacilli and enterococci by pteroylglutamic acid and related compounds, J. Biol. Chem. 166: 435, 1946. CrossrefMedlineGoogle Scholar17. LampenRoepkeJones JORRMJ: The replacement of p-aminobenzoic acid in the growth of a mutant strain of E. coli , J. Biol. Chem. 164: 789, 1946. CrossrefMedlineGoogle Scholar18. DayLangstonShukers PLWCCF: Leukopenia and anemia in the monkey resulting from vitamin deficiency, J. Nutrition 60: 637, 1935. CrossrefGoogle Scholar19. RobertsonFralaScottNorrisHeuser EIGFMLLCGF: Response of anemic chicks to pteroylglutamic acid, Proc. Soc. Exper. Biol and Med. 64: 441, 1947. CrossrefMedlineGoogle Scholar20. SchaeferWhitechairElvehjem AECKCA: Purified rations and the importance of folic acid in mink nutrition, Proc. Soc. Exper. Biol. and Med. 62: 169, 1946. CrossrefMedlineGoogle Scholar21. SpicerDaftSebrellAshburn SSFSWHLL: Prevention and treatment of agranulocytosis and leukopenia in rats given sulfanylguanidine or succinylsulfathiazole in purified diets, Pub. Health Rep. 57: 1559, 1942. CrossrefMedlineGoogle Scholar22. DaftSebrell FSWH: The successful treatment of granulocytopenia and anemia in rats fed sulfonamides in purified diets, Pub. Health Rep. 58: 1542, 1943. CrossrefGoogle Scholar23. JukesStokstad TAEL: Pteroylglutamic acid and related compounds, Physiol. Rev. 28: 51-106, 1948. CrossrefMedlineGoogle Scholar24. Williams RJ: B vitamins and cancer, Research Conference on Cancer (A. A. A. S.), 1944, 253. Google Scholar25. PollackTaylorWilliams MAARG: B vitamins in human, rat and mouse neoplasms, Univ. Texas Pub. No. 4237, 1942, 56. Google Scholar26. LeuchtenbergerLewisohnLaszloLeuchtenberger CRDR: "Folic acid" a tumor growth inhibitor, Proc. Soc. Exper. Biol. and Med. 204: 204, 1944. CrossrefGoogle Scholar27. LeuchtenbergerLeuchtenbergerLaszloLewisohn RCDR: The influence of "folic acid" on spontaneous breast cancers in mice, Science 150: 46, 1945. CrossrefGoogle Scholar28. Suguira K: Effect of intravenous injection of yeast and barley extracts and L. casei factor upon spontaneous mammary adenocarcinoma in mice, Approaches to Tumor Chemotherapy (A. A. A. S.), 1947, 208. Google Scholar29. ZahlHunter PASH: The growth inhibition of mouse sarcoma 180, Approaches to Tumor Chemotherapy (A. A. A. S.), 1947, 214. Google Scholar30. Hesselback ML: Approaches to tumor chemotherapy (A. A. A. S.), 1947, 196. Google Scholar31. LewisohnLeuchtenbergerLeuchtenbergerKeresztesy RCRJC: The influence of liver L. casei factor on spontaneous breast cancer in mice, Science 104: 436-437, 1946. CrossrefGoogle Scholar32. LittleSampathPaganelliLockeSubbaRow PAAVEY: The effect of folic acid and its antagonists on Rous chicken sarcoma, Tr. New York Acad. Sc. 10: 91-98, 1948. CrossrefGoogle Scholar33. SchoenbachGoldinGoldbergOrtega EBABLG: The effect of folic acid derivatives on sarcoma 180, Cancer 2: 57-64, 1949. CrossrefMedlineGoogle Scholar34. MooreStockSuguiraRhoads AECCKCP: Inhibition of development of sarcoma 180 by 4-amino-N10-methyl pteroylglutamic acid, Proc. Soc. Exper. Biol. and Med. 70: 396-398, 1949. CrossrefMedlineGoogle Scholar35. BurchenalBurchenalKushidaJohnstonWilliams JHJRMWSFBS: Studies on the chemotherapy of leukemia, Cancer 2: 113-118, 1949. CrossrefMedlineGoogle Scholar36. HigginsWoods GMKA: The effect of the folic acid antagonist, 4-aminopteroylglutamic acid on the growth of transplanted mammary tumors in C3H mice, Proc. Staff Meet., Mayo Clinic 24: 238-243, 1949. MedlineGoogle Scholar37. BermanAxelrodVonderHeideSharp LARECEA: Use of a folic acid antagonist in chronic leukemia, Am. J. Clin. Path. 19: 127, 1949. CrossrefMedlineGoogle Scholar38. AllenBogardusJacobsonSpurr JGLOCL: Some observations on the bleeding tendency in thrombocytopenic purpura, Ann. Int. Med. 27: 382, 1947. LinkGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: *Received for publication June 25, 1949.From the Department of Medicine of the University of Maryland School of Medicine and the Department of Preventive Medicine, Johns Hopkins University School of Medicine.This work was aided in part by a grant from the American Cancer Society to the Department of Preventive Medicine, Johns Hopkins University School of Medicine.Aminopterin and a-methopterin were supplied through the courtesy of the Lederle Laboratories Division of the American Cyanamid Co., New York, N. Y.†Baltimore Rh Laboratory Fellow in Medicine.The authors wish to express their appreciation to the following physicians for their courtesy and assistance in studying the cases presented in this report: Drs. J. Edmund Bradley, Tobias Weinberg, Milton Sherry, Hugh R. Spencer, H. Raymond Peters, Alexander J. Schaffer. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byFolate AntagonistsSynthesis and Evaluation of Hydrogen Peroxide Sensitive Prodrugs of Methotrexate and Aminopterin for the Treatment of Rheumatoid ArthritisMethotrexateMethotrexatePancreatic Proteolytic Enzyme Therapy Compared With Gemcitabine-Based Chemotherapy for the Treatment of Pancreatic CancerTransport of Aminopterin by Human Organic Anion Transporters hOAT1 and hOAT3: Comparison with MethotrexateCase files of the New York City Poison Control Center: Antidotal strategies for the management of methotrexate toxicityPhase II Trial of Oral Aminopterin for Adults and Children with Refractory Acute LeukemiaTHE FOLIC ACID COMPLEXMULTIPLE REMISSIONS IN AN ADULT WITH ACUTE LEUKEMIA TREATED PRINCIPALLY WITH A-METHOPTERIN*ESTHER FINCHER HAYS, M.D., THOMAS C. SCANLAN, M.D., RALPH L. ENGLE JR., M.D.PediatricsObservations on the effects of the folic acid antagonists, aminopterin and amethopterin, in patients with advanced neoplasmsThe effects of the folic acid antagonists and 2,6-diaminopurine on neoplastic disease.With special reference to acute leukemiaStudies on the mechanism of action of chemotherapeutic agents in cancer.V. Influence of the citrovorum factor and folic acid on the toxic manifestations of aminopterin in mice 1 January 1950Volume 32, Issue 1Page: 80-115KeywordsAmino acidsCancer preventionChildrenFolic acidMethotrexatePreventive medicine ePublished: 1 December 2008 Issue Published: 1 January 1950 PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
SACKS et al. (1950) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: